AI NEWS 24
Nvidia Bolsters AI Infrastructure Through Major Investments and Strategic Partnerships 95OpenAI Boosts AI Training Capabilities and Deploys Enhanced ChatGPT with Offline Features 92AI Landscape: Accelerated Adoption, Emerging Risks, and Next-Generation Development 90Anthropic's Claude AI Navigates Safety Exploits, Market Risks, and Capacity Expansion 90Widespread AI Integration and Impact Across Diverse Industries 90Google Gemini AI Expansion and Security Concerns 90Global Oil Buffers Draining Due to Iran War, Boosting Producer Profits 90ByteDance Targets 25% Rise in AI Infrastructure Spending 90AI's Market Impact: Strong Growth Tempered by Valuation and Sustainability Concerns 88Alibaba to Integrate Qwen AI with Taobao, Launching 'Agentic Shopping' 88///Nvidia Bolsters AI Infrastructure Through Major Investments and Strategic Partnerships 95OpenAI Boosts AI Training Capabilities and Deploys Enhanced ChatGPT with Offline Features 92AI Landscape: Accelerated Adoption, Emerging Risks, and Next-Generation Development 90Anthropic's Claude AI Navigates Safety Exploits, Market Risks, and Capacity Expansion 90Widespread AI Integration and Impact Across Diverse Industries 90Google Gemini AI Expansion and Security Concerns 90Global Oil Buffers Draining Due to Iran War, Boosting Producer Profits 90ByteDance Targets 25% Rise in AI Infrastructure Spending 90AI's Market Impact: Strong Growth Tempered by Valuation and Sustainability Concerns 88Alibaba to Integrate Qwen AI with Taobao, Launching 'Agentic Shopping' 88
← Back to Briefing

WHO Opens Application Period for 2027 Essential Medicines List Update

Importance: 50/1001 Sources

Why It Matters

The WHO Model Lists of Essential Medicines serve as a global benchmark, guiding countries on which medicines to prioritize for universal access and national health systems. Updating these lists ensures they reflect the latest medical advancements and public health needs, impacting access to vital treatments worldwide.

Key Intelligence

  • The World Health Organization (WHO) has officially opened the application period for the 2027 update of its Model Lists of Essential Medicines (EML).
  • This regular review process is crucial for ensuring the EML remains relevant by considering new medicines for inclusion or modifications to existing listings.
  • The call for applications allows global health stakeholders to propose essential medicines for consideration in the upcoming 2027 edition.